Zarontin Capsule
Product Images NDC 0071-0237

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zarontin (NDC 0071-0237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Parke-davis Div Of Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zarontin 01)

Chemical structure of Ethosuximide, the active ingredient in Zarontin 250 mg capsules by Parke-Davis Div of Pfizer Inc. The diagram depicts the molecule's ring and side-chain components in a skeletal formula format.*

FDA Label Image

Company Logo (Zarontin 02)

FDA Label Image

Zarontin 02a

FDA Label Image

Principal Display Panel (250 mg Capsule Bottle Label)

Zarontin 250 mg capsules label showing the prescription drug name and strength, active ingredient ethosuximide, oral capsule dosage form, package size of 100 capsules, and labeled by Parke-Davis Division of Pfizer Inc. The label includes storage instructions, a note to dispense in child-resistant containers, the NDC 0071-0237-24, and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.